key: cord-0814659-9bdtxhow
authors: Zhu, Jialou; Guo, Jiubiao; Xu, Yuzhong; Chen, Xinchun
title: Viral dynamics of SARS-CoV-2 in saliva from infected patients
date: 2020-06-25
journal: J Infect
DOI: 10.1016/j.jinf.2020.06.059
sha: 22bac8e6fc8d599b28d3d3e9d439a00fc4b304ef
doc_id: 814659
cord_uid: 9bdtxhow

nan

We read with great interest the recent study by Azzi et al. (1) who reported that saliva was a reliable tool to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and further confirmed by Iwasaki et al. (2) that saliva was a noninvasive alternative to nasopharyngeal (NP) swabs. To At present, the "gold" standard to detect SARS-CoV-2 infection is by real-time reverse-transcription-polymerase-chain-reaction (RT-PCR) in respiratory tract specimens, mainly nasopharyngeal (NP) and oropharyngeal (OP) swabs. However, the collection of these specimens is a relatively invasive procedure, which causes severe discomfort. In particular, the close contact involved in swab collection might put healthcare workers at higher risk for viral transmission.

Saliva specimens, in contrast, can be easily self-collected by patients. Findings of previous studies have demonstrated successful detection of SARS-CoV-2 RNA in saliva, proving it as an appealing noninvasive alternative to NP or OP swabs for the diagnosis and viral load monitoring of SARS-CoV-2 (1-3). However, the clinical usefulness of saliva specimens for diagnosing COVID-19 has yet to be thoroughly evaluated due to the small sample size. Besides, the viral load dynamics in saliva samples and the relationship between viral load and disease severity are also unknown. Here, we compared the detection sensitivity of paired respiratory tract and saliva specimens in diagnosing COVID-19, and described the temporal profile of viral loads in patients with mild and severe COVID-19 in saliva.

In total, 944 patients from 12 independent cohorts were included (Table S1 ). To determine the diagnostic performance of real-time RT-PCR in saliva, the RT-PCR results from respiratory tract samples were used as reference. Among them, 442 cases were confirmed with SARS-CoV-2 infection by real-time RT-PCR in respiratory tract specimens (Table 1 ). Of these, 382 patients were SARS-CoV-2 positive in both saliva and respiratory tract specimens, and 60 patients tested positive only in respiratory tract samples. In 502 patients whose respiratory tract specimens tested negative for SARS-CoV-2, 15 saliva specimens had viral RNA detectable. When compared to the respiratory tract samples, the sensitivity and specificity of saliva were 86.4% (95% CI 82.8%-89.4%) and 97.0% (95% CI 95.0%-98.3%), respectively. Analysis of the concordance revealed a 92.1% observed virus detection accuracy and a firm agreement of diagnosis between the respiratory tract and saliva sample (Kohen's kappa coefficient 0.840, 95% CI 0.805-0.874).

In addition, with the aim to illustrate the viral RNA shedding pattern in saliva and predict its correlation with illness severity in patients with COVID-19, 126 saliva specimens were serially collected from 20 patients, with 11 (55%) individuals classified as mild cases and 9 (45%) classified as severe cases. Our data indicated that the SARS-CoV-2 RNA levels in saliva peaked soon in one week after symptom onset, ranging from around 10⁴ to 10 8 copies per mL during this time, then steadily declined ( Figure 1A ). 40% (8/20) patients had a viral shedding period longer than 14 days in saliva. The prolonged presence of SARS-CoV-2 viral RNA in saliva samples was not associated with disease severity (p=0.535). We further analyzed the correlation between viral loads in saliva and severity of illness according to the day after disease onset at the time of sampling. The mean viral load of severe cases showed no significant difference from those of corresponding mild cases for all the indicated period ( Figure 1B) . The viral RNA clearance patterns in saliva samples were also observed similarly in mild and severe COVID-19 patients ( Figure 1C, D) .

In this study, we proved saliva as an acceptable noninvasive alternative source for the diagnosis and viral load monitoring of SARS-CoV-2 in a large cohort of patients. Saliva exhibited comparable sensitivity and strong agreement to the current COVID-19 diagnosis standard by using respiratory tract specimens. Of interest, saliva tested positive in 15 patients from whom respiratory tract specimens were negative for SARS-Cov-2, raising the contagious possibility through their saliva even when swabs are negative. Moreover, collecting specimens with saliva has several advantages over NP and OP swabs. The process of collecting saliva is noninvasive and can be reliably self-administered, reducing the exposure and virus transmission risk to healthcare workers, and decreasing supply demands on swabs and personal protective equipment.

Higher salivary viral loads were detected soon after symptom onset and subsequently declined with time in our cohort study. It was consistent with previous findings in throat swab and sputum samples (4), as well as in saliva samples (5) . Viral loads in saliva were comparable to those in sputum and throat swabs as well (4), varying from about 10⁴ to 10 8 copies per mL during the first week of symptoms. The RNA shedding pattern was distinct from that in patients infected with SARS-CoV, which typically peaked at around ten days after onset of illness (6) . The high viral load on presentation suggested that early antiviral treatment might benefit the recovery for patients with COVID-19. A similar viral RNA shedding pattern in saliva was observed in mild and severe COVID-19 patients, but differed from what presented in NP swabs (7) . It might be due to the prolonged presence of SARS-CoV-2 viral RNA in saliva samples, while NP swabs became negative over time (8, 9) .

In summary, our study showed that saliva might serve as a promising substitutable choice to the current COVID-19 diagnosis standard by using respiratory tract specimens with comparable performance. Salivary viral load peaked during the first week of symptoms and gradually declined over time. Surprisingly, there was no significant difference regarding the temporal viral load profile between mild and severe cases in our study. Further investigation in a larger cohort is warranted to reveal the correlation between salivary viral loads and disease severity.

This study was approved by the Institutional Ethics Board and informed consent was obtained from all patients

The authors declare that they have no competing financial interests. 

Saliva is a reliable tool to detect SARS-CoV-2. The Journal of infection

Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva. The Journal of infection

Pubmed Central PMCID: PMC7270800 interests

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Viral load of SARS-CoV-2 in clinical samples. The Lancet Infectious diseases

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. The Lancet Infectious diseases

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

Viral dynamics in mild and severe cases of COVID-19. The Lancet Infectious diseases

Two cases of COVID-19 with positive salivary and negative pharyngeal or respiratory swabs at hospital discharge: A rising concern